Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-23-049759

Chief Development Officer sold 4,104 shares at $6.62 ($27,168)

From the SEC's structured data for this filing

Trades in this filing

Jalota Deepika · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-15 Sale : show line 1 in the form −4,104 $6.62 $27,168 29,946 D
Open-market sales · 4,104 sh · avg $6.62 · $27,168
Loading xslF345X05/doc4.xml…